3 New Strong Buy Ratings from Top-Rated Analysts: 07/03/2026
Before the market closes, here are 3 stocks to consider adding to your watchlist — all favored by our market-beating Zen Ratings system…
- Cenovus Energy (CVE) — Integrated energy leader eyes 92% upside on efficiency gains.
- Omnicell (OMCL) — Healthcare automation leader ranks #1 with 45% upside ahead.
- Nvidia (NVDA) — AI chip titan targets 115% upside as data centers boom.
P.S. Get more alerts like this daily … Try WallStreetZen Premium.
A note from our sponsors...
Bitcoin Got the Idea Right. It Got the Backing Wrong.
Bitcoin proved millions want money no government can print. But it's backed by nothing but belief.
What happens when you keep everything it got right — and back it with real, verified gold? You find out July 8.
1. Cenovus Energy (NYSE: CVE)
Operational efficiency is transforming Cenovus Energy's bottom line. The company produces crude oil, natural gas liquids, and natural gas from oil sands assets in Alberta, Canada, with refining operations in the U.S. — and tight global oil markets combined with improved efficiency across its integrated upstream and downstream assets are driving stronger returns.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $24.50 — get current quote
Max 1-year forecast: $47.00
Why we're watching:
- CVE has limited, but overall bullish, coverage among the analysts we track, with 1 Strong Buy and 1 Buy recommendations. See all recommendations here
- For example, Goldman Sachs researcher Neil Mehta (a top 6% rated analyst) maintained his Strong Buy rating with a $29.00 price target, representing 17% upside potential from current levels.
- Additionally, RBC Capital researcher Gregory Pardy (a top 11% rated analyst) maintained his Buy with a $47.00 price target, representing 92% upside potential from current levels.
- Industry ranking context: CVE is currently the #1 highest-rated stock in the Oil & Gas Integrated industry, which has an Industry Rating of A.
- Zen Ratings highlights: CVE holds an overall A rating, which equals a Strong Buy recommendation. Stocks with this rating have historically beaten the S&P with nearly 30% average annual returns.
- Component Grades: CVE excels with an A for Momentum alongside strong Bs for Financials, Growth, and Value, reflecting the company's improving cash flow generation and attractive positioning in a favorable energy price environment. See all 7 Component Grades here
2. Omnicell (NASDAQ: OMCL)
Healthcare providers are racing to improve operational efficiency — and Omnicell is powering that transformation. The company provides healthcare technology solutions to hospitals and health systems across the United States and internationally, with automation platforms for medication management and supply chain optimization seeing renewed demand.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $41.93 — get current quote
Max 1-year forecast: $70.00
Why we're watching:
- OMCL has limited, but overall bullish, coverage among the analysts we track, with 4 Strong Buy recommendations. See all recommendations here
- For example, Benchmark researcher Bill Sutherland (a top 11% rated analyst) maintained his Strong Buy rating with a $60.00 price target, representing 45% upside potential from current levels.
- Industry ranking context: OMCL is currently the #1 highest-rated stock in the Health Information Service industry, which has an Industry Rating of C.
- Zen Ratings highlights: OMCL earns an overall A rating, which is equal to a Strong Buy recommendation. Stocks in this topmost tier have historically delivered nearly 30% annual returns, soundly beating the S&P.
- Component Grades: OMCL excels with As for Growth and Sentiment alongside a strong B for Safety, reflecting the company's impressive earnings growth trajectory and positive analyst outlook amid a recovering healthcare capital spending environment. See all 7 Component Grades here
3. Nvidia Corp (NASDAQ: NVDA)
Beyond the data center, NVIDIA is quietly conquering the next frontiers of AI. The company stands as a prominent provider of advanced graphics, computational, and networking solutions across the United States, Taiwan, China, and numerous international markets — dominating the AI accelerator market while expanding into edge AI, robotics, and sovereign AI deployments that drive sustained demand for its data center platforms.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $197.58 — get current quote
Max 1-year forecast: $500.00
Why we're watching:
- NVDA has strong, bullish coverage among the analysts we track, with 18 Strong Buy and 8 Buy recommendations. See all recommendations here
- For example, Needham researcher Quinn Bolton (a top 1% rated analyst) reiterated his Buy rating with a $270.00 price target, representing 37% upside potential from current levels.
- Likewise, Tigress Financial researcher Ivan Feinseth (a top 4% rated analyst) maintained his Strong Buy with a $425.00 price target, representing 115% upside potential from current levels.
- Six additional top 1% analysts covering NVDA include UBS's Timothy Arcuri, Evercore ISI Group's Mark Lipacis, Truist Securities' William Stein, RBC Capital's Srini Pajjuri, Cantor Fitzgerald's C.J. Muse, and Wedbush's Matt Bryson — all maintaining bullish outlooks on the AI semiconductor leader's growth trajectory.
- Industry ranking context: NVDA is currently the #4 highest-rated stock in the Semiconductor industry, which has an Industry Rating of B.
- Zen Ratings highlights: NVDA carries an overall B rating, equal to a Buy recommendation. This designation places it among the top 20% of stocks tracked by our comprehensive 115-factor fundamental analysis framework, with historical average annual returns of over 17%
- Component Grades: NVDA shines with an A for Financials, reflecting its exceptional profit margin and return on equity, while maintaining solid Bs for Value and AI, positioning the company well as the AI infrastructure buildout continues. See all 7 Component Grades here
What to Do Next?
Want to get in touch? Email us at news@wallstreetzen.com.
Keep Reading
See All News
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.